Optimizing Pharmaceutical Supply Chain Performance:优化医药供应链绩效.ppt

Optimizing Pharmaceutical Supply Chain Performance:优化医药供应链绩效.ppt

  1. 1、本文档共27页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Optimizing Pharmaceutical Supply Chain Performance:优化医药供应链绩效

9/18/2003 Balancing Capacity, Expense And Inventory To Maximize Customer Service And Increase Profitability Ken Thomas Manager, MSSC Capabilities Pharmaceutical Supply Chain Management: Optimizing Customer Service and Corporate Results “Pulling the right levers” will improve the balance of customer service level, cost, flexibility and risk management to fit the marketplace needs of each product 1. Capacity Strategy: Global capacity with contingency 2. Sourcing Optimization: A Lilly-focused quantitative analysis… …augmented with qualitative considerations Final decision: Can revenue be increased by using third party manufacturing? 3. Final decision: Can revenue be increased by using third party manufacturing? Supply Chain Design Summary Supply Chain Operations: Maintaining 100% Customer Service Level and Maximizing Efficiency 2. Inventory Management: Patient Needs and Financial Realities Demand a Service-based Approach to API and Finished Stock Inventories. 3. Global Supply Chain Planning (GSOP) 4. Global capacity balancing and profitability optimization: Making the ‘doable’ version 1 plan better SC Operations Summary The opportunities for impact are increased when the scope of thinking extends beyond manufacturing to all functions in the Value Chain. Stronger integration is critical Lilly’s own journey towards a better integration. Virtual Firms The IT Tools We Know Can Simulate Our Supply Chains Competency Model: Demand Management Coordinator *Ken Thomas Copyright ? 2000 Eli Lilly and Company Customer service the priority, inventory control secondary Cost of inventory vs. value of a sale Idle capacity is desirable, at the right place and right time Capital intensity of manufacturing Outsourcing risk evaluation needs to balance cost reduction Technical/regulatory complexities of manufacturing Limited, slow and expensive sourcing changes Registration ties sourcing decision to market access SC design completed years before launch Regula

文档评论(0)

zhuwenmeijiale + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:7065136142000003

1亿VIP精品文档

相关文档